A simple white user icon with a circular head and shoulders on a solid purple background.

Amir Azadi, M.D.

Research Division
Programs

Biography

Biography · Medical School: Shahid Beheshti University of Medical Sciences – Tehran · Residency: Banner University Medical Center-Phoenix – Phoenix · Oncology Fellowship: University of Louisville School of Medicine – Louisville, Ky. . Neuro-oncology Fellowship: Barrow Neurological Institute at St. Joseph’s Hospital and Medical Center – Phoenix · Board Certification: American Board of Internal Medicine: Internal Medicine, Hematology and Medical Oncology · Languages: English and Farsi Dr. Azadi specializes in Neuro-Oncology, focusing on brain, spine, skull-based tumors and head and neck malignancies. His expertise includes the diagnosis and treatment of brain and head and neck tumors. Dr. Azadi’s research interests include precision medicine and immunotherapy in primary and secondary brain tumors. Dr. Azadi’s priority is to provide his patients with personalized, compassionate care using the most up-to-date treatment options. He listens to his patients, and collaboratively they choose the best treatment option for their cancer. He strives to deliver the most effective cancer management and treatment strategies, while providing encouragement and support for his patients. In his free time, Dr. Azadi enjoys all sports, especially tennis and mountain biking.

Research Interests & Focus

Dr. Amir Azadi’s interests are in Translational and Clinical research in Primary Brain Tumor, including Glioblastoma:
• Clinical Trials: Neuro-oncology programs are involved in clinical trials that offer cutting-edge treatments and therapies for brain and CNS tumors. Patients may have the opportunity to participate in these trials, which can provide access to the latest advancements in the field.
• Research and Innovation: Neuro-oncology programs collaborate with HRI in research to develop more effective treatments.
His focus is:
Bringing Neuro-Oncology programs to the next level where patients will want to come from other hospital systems:    
1. Multidisciplinary clinical trial treatment team.
2. Up-to-date and leading-edge treatment capability, including multiple treatment protocols and advanced treatment tools and equipment.